An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor
- 13 July 2008
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 131 (1), 64-69
- https://doi.org/10.1016/j.jconrel.2008.07.006
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNAMolecular Therapy, 2008
- Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticlesJournal of Controlled Release, 2008
- Tumor-targeted Delivery of siRNA by Self-assembled NanoparticlesMolecular Therapy, 2008
- Sticky overhangs enhance siRNA-mediated gene silencingProceedings of the National Academy of Sciences, 2007
- Preparation and Biologic Evaluation of a Novel Radioiodinated Benzylpiperazine, 123I-MEL037, for Malignant MelanomaJournal of Nuclear Medicine, 2007
- Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug deliveryInternational Journal of Pharmaceutics, 2007
- Surface‐Modified LPD Nanoparticles for Tumor TargetingAnnals of the New York Academy of Sciences, 2006
- Targeted Delivery of Antisense Oligodeoxynucleotide and Small Interference RNA into Lung Cancer CellsMolecular Pharmaceutics, 2006
- Anisamide‐targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cellsInternational Journal of Cancer, 2004
- CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract.JCI Insight, 1997